Clinimix E 58.5 mg (Sodium Chloride SOLUTION) 58.5 MG

Clinimix E 58.5 mg is an intravenous solution containing sodium chloride, designed for medical use. This product is manufactured by Baxter Corporation in Canada and is available in a 1000ml pack size.

Strength

58.5 MG

Pack Size

1000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix E 58.5 mg is primarily used for intravenous administration to provide essential electrolytes and fluids. It is often utilized in clinical settings to maintain hydration and electrolyte balance, particularly in patients who cannot take oral medications. The solution is formulated to support various medical conditions requiring fluid and electrolyte replacement.

Side Effects

When administered intravenously, Clinimix E 58.5 mg works by delivering sodium chloride directly into the bloodstream. This helps to replenish electrolytes and maintain proper fluid balance in the body. The effects are typically observed quickly due to the direct administration method.

Precautions & Warnings

Clinimix E 58.5 mg should be used under medical supervision. It is important to follow the prescribed administration guidelines to avoid potential complications. Patients with certain medical conditions, such as kidney disease or heart problems, should use this solution with caution.

Avoid Interactions

Clinimix E 58.5 mg may interact with other medications or treatments. It is advisable to inform healthcare providers about all current medications before using this solution. Additionally, interactions with other intravenous solutions or electrolytes should be considered.

Frequently Asked Questions

Clinimix E 58.5 mg is used for intravenous administration to provide essential electrolytes and fluids, supporting hydration and electrolyte balance in patients who cannot take oral medications.

Clinimix E 58.5 mg is administered intravenously, typically under medical supervision, to deliver sodium chloride directly into the bloodstream.

The common effects of Clinimix E 58.5 mg include replenishing electrolytes and maintaining proper fluid balance in the body, which can be observed quickly due to the direct administration method.

Yes, Clinimix E 58.5 mg should be used under medical supervision, and patients with certain medical conditions should use it with caution.

Yes, Clinimix E 58.5 mg may interact with other medications or treatments, so it is important to inform healthcare providers about all current medications before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.